DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Dodick DW, Goadsby PJ, Silberstein SD et al.
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial.
Lancet Neurol 2014;
13: 1100-1107
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.